A Study of ESO-T01 in Treating Relapsed/ Refractory Multiple Myeloma

Clinical trial NCT06791681 · RECRUITING

Trial details

NCT number: NCT06791681
Sponsor: Chunrui Li
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Relapsed/ Refractory Multiple Myeloma

Start date: 2025-01-27
Primary completion: 2027-11-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.